DIABETIC MACROANGIOPATHY

This adverse event was reported 29 times

These drugs are most commonly taken by patients reporting DIABETIC MACROANGIOPATHY:

# Drug Count
0 BASILIXIMAB 15
1 MIDAZOLAM HYDROCHLORIDE 15
2 TACROLIMUS 15
3 MIDAZOLAM 14
4 TACROLIMUS CAPSULES 14
5 CLOPIDOGREL BISULFATE 13
6 LINEZOLID 13
7 CLOPIDOGREL 12
8 TICAGRELOR 12
9 CIPROFLOXACIN 11
See all common drugs associated with DIABETIC MACROANGIOPATHY

DIABETIC MACROANGIOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BASILIXIMAB 15 0.0019
1 NOREPINEPHRINE (BITARTRATE) 8 0.0012
2 PIPERACILLIN AND TAZOBACTAM 9 0.0012
3 PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM 9 0.0011
4 PIPERACILLIN SODIUM,TAZOBACTAM SODIUM 10 0.0010
5 MYCOPHENILIC ACID 8 0.0009
6 MIDAZOLAM HYDROCHLORIDE 15 0.0009
7 LINEZOLID 13 0.0007
8 MEROPENEM 11 0.0005
9 TICAGRELOR 12 0.0005
See all drugs enriched for association with DIABETIC MACROANGIOPATHY